首页> 美国卫生研究院文献>other >Vascular-Targeted Nanocarriers: Design Considerations and Strategies for Successful Treatment of Atherosclerosis and Other Vascular Diseases
【2h】

Vascular-Targeted Nanocarriers: Design Considerations and Strategies for Successful Treatment of Atherosclerosis and Other Vascular Diseases

机译:血管靶向纳米载体:设计考虑因素和成功治疗动脉粥样硬化和其他血管疾病的策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vascular-targeted nanocarriers are an attractive option for the treatment of a number of cardiovascular diseases, as they allow for more specific delivery and increased efficacy of many small molecule drugs. However, immune clearance, limited cellular uptake, and particle-cell dynamics in blood flow can hinder nanocarrier efficacy in many applications. This review aims to investigate successful strategies for the use of vascular-targeted nanocarriers in the treatment of cardiovascular diseases such as atherosclerosis. In particular, the review will highlight strategies employed for actively targeting the components of the atherosclerotic plaque, including endothelial cells, macrophages, and platelets and passive targeting via endothelial permeability, as well as design specifications (such as size, shape, and density) aimed at enhancing the ability of nanocarriers to reach the vascular wall.
机译:靶向血管的纳米载体是治疗多种心血管疾病的一种有吸引力的选择,因为它们可以实现更特异性的递送并提高许多小分子药物的疗效。然而,在许多应用中,免疫清除,有限的细胞摄取以及血流中的颗粒细胞动力学会阻碍纳米载体的功效。这项审查旨在调查成功的策略,以血管为靶标的纳米载体用于治疗心血管疾病,如动脉粥样硬化。尤其是,该综述将重点介绍用于主动靶向动脉粥样硬化斑块成分(包括内皮细胞,巨噬细胞和血小板)的策略以及通过内皮渗透性被动靶向的策略,以及旨在针对的设计规范(例如尺寸,形状和密度)增强纳米载体到达血管壁的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号